The FDA will only look at safety from the p11 trial to consider approval not efficacy . The efficacy of the drug will be proven or otherwise by the P111 trial now we know some of the limitations in the data from the US from the P11 result.
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-502
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $640.6M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 36.0¢ | 35.0¢ | $670.2K | 1.898M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 118085 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 458484 | 22 |
View Market Depth
| Last trade - 11.12am 17/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |